Pfizer reported Q1 FY 2016 earnings of $0.67 per share (versus $0.51 in Q1 FY 2015), beating analysts’ consensus of $0.55.
The company’s quarterly revenues amounted to $13.005 bln (+19.3% y/y), beating consensus estimate of $12.008 bln.
Pfizer also issued upside guidance for FY 2016, projecting EPS of $2.38-2.48 (versus analysts’ consensus of $2.28) and revenues of $51.0-53.0 bln (versus analysts’ consensus of $51.31 bln).
PFE rose to $33.68 (+2.68%) in pre-market trading.
The post Company News: Pfizer (PFE) Q1 results beat analysts’ expectations appeared first on forex-analytics.press.